Table 2: Results of meta-analysis for ERCC1
C8092A and C118T and the risk of glioma.
Genetic model |
Dominant
model |
Recessive
model |
Co-dominant
model |
Co-dominant
model |
Additive
model |
||||||||||
C8092A |
AA/AC
vs. CC |
AA
vs. AC/CC |
AA
vs. CC |
AC
vs. CC |
A
vs. C |
||||||||||
OR (95% CI) |
Ph |
I2 (%) |
OR (95% CI) |
Ph |
I2 (%) |
OR (95% CI) |
Ph |
I2 (%) |
OR (95% CI) |
Ph |
I2 (%) |
OR (95% CI) |
Ph |
I2 (%) |
|
Total |
1.04 (0.94,1.16) |
0.586 |
0 |
1.51 (1.24,1.85) |
0.335 |
12.6 |
1.52 (1.24,1.86) |
0.37 |
6.8 |
0.98 (0.88,1.09) |
0.666 |
0 |
1.1 (1.02,1.20) |
0.558 |
0 |
Ethnicity |
|||||||||||||||
Chinese |
1.12 (0.95,1.33) |
0.962 |
0 |
1.34 (1.02,1.75) |
0.566 |
0 |
1.37 (1.03,1.81) |
0.65 |
0 |
1.06 (0.89,1.27) |
0.894 |
0 |
1.15 (1.01,1.30) |
0.832 |
0 |
Caucasian |
1.00 (0.88,1.14) |
0.281 |
21.1 |
1.75 (1.31,2.34) |
0.259 |
25.9 |
1.70 (1.27,2.29) |
0.19 |
39.7 |
0.93 (0.82,1.07) |
0.418 |
0 |
1.08 (0.97,1.19) |
0.22 |
33.9 |
C118T |
TT/CT vs. CC |
TT vs. CT/CC |
TT vs. CC |
CT vs. CC |
T vs. C |
||||||||||
OR (95%
CI) |
Ph |
I2
(%) |
OR (95%
CI) |
Ph |
I2
(%) |
OR (95%
CI) |
Ph |
I2
(%) |
OR (95%
CI) |
Ph |
I2
(%) |
OR (95%
CI) |
Ph |
I2
(%) |
|
Total |
1.04 (0.89,1.22) |
0.478 |
0 |
0.99 (0.83,1.19) |
0.116 |
49.2 |
1.04 (0.84,1.29) |
0.12 |
48.7 |
1.03 (0.87,1.22) |
0.818 |
0 |
1.02 (0.91,1.13) |
0.119 |
48.7 |
Abbreviations:
Ph: p values for heterogeneity from Q test, random-effects model was
used when p values for heterogeneity test < 0.10; otherwise, fixed-effects
model was used.